‹ ›
MYP_044803
← PREVIOUS NEXT → BACK
Basic Information
6K-1426
Antimicrobial
Standard
19 amino acids
C107H195N27O21
Standard
Sequence
KKKKKKFLPKLLSALAKIL
Physicochemical Analysis
2195.86 Da
10.85
7.75
7.54
0.4080
-0.19
0.60
-0.16
20.81
133.68
0.0526
0.00
0.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
806.72
-1.79
28.0
29.0
83.0
155.0
2.0
18.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0005656 VERIFIED: YES
Provenance & Taxonomy
synthetic construct based on Designed based an [Synthetic]
Temporin
32630
Structure & Mods
synthetic linear peptide [Linear]
canonical L-amino-acid peptide [L]
Amidation
APD analysis reveals that this sequence is similar (80%) to 6K-WY2 Leu: 26%; K: 42%; A: 11%. Chemical modification: C-terminal amidated
Bio-Activity Profile
Antimicrobial
Klebsiella pneumoniae ATCC 43816
2 μM
MIC
PaperDiscovery and engineering of a novel peptide, Temporin-WY2, with enhanced in vitro and in vivo efficacy against multi-drug resistant bacteria
RECORD: Rec_0163422 VERIFIED: YES
Provenance & Taxonomy
synthetic construct based on Designed based an [Synthetic]
Temporin
32630
Structure & Mods
synthetic linear peptide [Linear]
canonical L-amino-acid peptide [L]
Amidation
APD analysis reveals that this sequence is similar (80%) to 6K-WY2 Leu: 26%; K: 42%; A: 11%. Chemical modification: C-terminal amidated
Bio-Activity Profile
Antimicrobial
Escherichia coli NCTC 8739 or clinical BAA 2340
2 μM
MIC
PaperDiscovery and engineering of a novel peptide, Temporin-WY2, with enhanced in vitro and in vivo efficacy against multi-drug resistant bacteria
RECORD: Rec_0219260 VERIFIED: YES
Provenance & Taxonomy
synthetic construct based on Designed based an [Synthetic]
Temporin
32630
Structure & Mods
synthetic linear peptide [Linear]
canonical L-amino-acid peptide [L]
Amidation
APD analysis reveals that this sequence is similar (80%) to 6K-WY2 Leu: 26%; K: 42%; A: 11%. Chemical modification: C-terminal amidated
Bio-Activity Profile
Antimicrobial
Disrupt preformed biofilms: Escherichia coli
32 μM
MBEC
PaperDiscovery and engineering of a novel peptide, Temporin-WY2, with enhanced in vitro and in vivo efficacy against multi-drug resistant bacteria
RECORD: Rec_0401872 VERIFIED: YES
Provenance & Taxonomy
synthetic construct based on Designed based an [Synthetic]
Temporin
32630
Structure & Mods
synthetic linear peptide [Linear]
canonical L-amino-acid peptide [L]
Amidation
APD analysis reveals that this sequence is similar (80%) to 6K-WY2 Leu: 26%; K: 42%; A: 11%. Chemical modification: C-terminal amidated
Bio-Activity Profile
Antimicrobial
Pseudomonas aeruginosa ATCC 9027 or PA14 or PAO1
2-16 μM
MIC
PaperDiscovery and engineering of a novel peptide, Temporin-WY2, with enhanced in vitro and in vivo efficacy against multi-drug resistant bacteria
RECORD: Rec_0408615 VERIFIED: YES
Provenance & Taxonomy
synthetic construct based on Designed based an [Synthetic]
Temporin
32630
Structure & Mods
synthetic linear peptide [Linear]
canonical L-amino-acid peptide [L]
Amidation
APD analysis reveals that this sequence is similar (80%) to 6K-WY2 Leu: 26%; K: 42%; A: 11%. Chemical modification: C-terminal amidated
Bio-Activity Profile
Antimicrobial
Enterococcus faecalis NCTC 12697
16 μM
MIC
PaperDiscovery and engineering of a novel peptide, Temporin-WY2, with enhanced in vitro and in vivo efficacy against multi-drug resistant bacteria
1 2 NEXT LAST
Showing 5 records on this page · Page 1 of 2